抗C3bBb自身抗体的功能特征与C3肾小球病表型
研究纳入27例C3肾小球病或Ig介导的膜增生性肾小球肾炎患者,用Luminex法检测IgG对替代途径C3转化酶(C3bBb)形成和稳定的影响。18/27例患者IgG可增强C3bBb形成和/或稳定,双功能抗体阳性者C3水平均低且5年肾脏生存率70%低于阴性者100%。
要点
- 双功能抗C3bBb抗体与严重C3消耗和较差肾脏生存相关。
- C3bBb形成水平与血浆C3相关,稳定功能与C3或sC5b-9无关。
- Luminex法可区分C3肾炎因子对C3bBb形成和稳定的不同功能。
核心结论
- C3bBb形成和稳定的双功能抗体与C3肾小球病和Ig-MPGN中严重C3消耗及较差肾脏生存相关。
研究设计与样本
- 研究纳入27例C3肾小球病(n=21)或Ig-MPGN(n=6)患者,78%为儿童起病。
- 采用新型Luminex法筛查影响替代途径C3转化酶(C3bBb)形成和/或稳定的IgG。
主要发现
- 18/27例患者IgG可增强C3bBb形成和/或稳定,其中9例双功能、6例仅增强形成、3例仅稳定。
- 所有双功能患者C3水平均低,而无双功能者中55% C3水平低。
- C3bBb形成水平与血浆C3相关,但与可溶性C5b-9无关;稳定功能与C3或可溶性C5b-9均无关。
- 末次随访时5/27例(19%)进展至肾衰竭,中位时间87(52–119)个月。
- 双功能抗C3bBb抗体阳性者5年肾脏生存率70%,阴性者100%(P=0.02)。
关键数值与推荐
- 采样时,低C3患者中13/19例(68%)经溶血法检测C3肾炎因子阳性,正常C3患者中8/8例(100%)阳性。
临床怎么用
- 对C3肾小球病和Ig-MPGN患者可检测抗C3bBb抗体功能(形成和稳定),双功能阳性提示C3消耗重且肾脏预后差。
局限性
- 样本量较小(27例),需更大队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Dysregulation of the C3bBb convertase is a key factor in the pathogenesis of C3 glomerulopathy and primary Ig-mediated membranoproliferative GN. IgG-driven increase of the C3bBb convertase formation was correlated with C3 consumption. IgG antibodies that promote the formation and the stabilization of the C3bBb convertase were associated with the severity of C3 glomerulopathy. BACKGROUND: C3 nephritic factors, that is, autoantibodies that stabilize the C3 convertase of the alternative pathway are the most frequent acquired abnormality in C3 glomerulopathy and primary Ig-mediated membranoproliferative GN (Ig-MPGN). METHODS: Our study included 27 patients with C3 glomerulopathy (n=21) or Ig-MPGN (n=6), of whom 78% were children at disease onset. At the time of sampling, 13/19 patients (68%) with low C3 levels and 8/8 patients (100%) with normal C3 levels were positive for C3 nephritic factors by hemolytic assay. Using novel Luminex assays, we performed a screening for IgG that recognize and affect the formation and/or the stabilization of the alternative pathway C3 convertase (C3bBb). RESULTS: Using Luminex assays, an increase in C3bBb formation and/or stabilization was observed in the presence of IgG from 18/27 patients, including nine with a double-function, six only enhancing the C3bBb formation, and three that exclusively stabilized C3bBb. All patients presenting a formation and stabilization function had a low C3 level versus 55% without this double-function. The level of C3bBb formation correlated to the plasmatic C3 but not soluble C5b-9 levels. The stabilization of C3bBb did not correlate with C3 or soluble C5b-9 levels. At the last follow-up, 5/27 patients (19%) reached kidney failure after a median delay of 87 (52–119) months. The patients positive for double-function anti-C3bBb antibodies had a 5-year kidney survival of 70% compared with 100% in those negative (P = 0.02). CONCLUSIONS: Our findings highlight the association of the dual function of C3bBb formation and stabilization with severe C3 consumption and poor kidney survival in C3 glomerulopathy and Ig-MPGN.
引用
- Roquigny J, Meuleman MS, El Sissy C, et al. Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype. J Am Soc Nephrol. 2024. PMID: 39325562. doi:10.1681/ASN.0000000000000499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。